These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36258171)

  • 1. Medication use by US patients with pulmonary hypertension associated with chronic obstructive pulmonary disease: a retrospective study of administrative data.
    Weiss TJ; Rosen Ramey D; Yang L; Liu X; Patel MJ; Rajpathak S; Bajwa EK; Lautsch D
    BMC Pulm Med; 2022 Oct; 22(1):383. PubMed ID: 36258171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient and Therapeutic Profiles of Pulmonary Hypertension in Chronic Lung Diseases in Japan: A Cohort Study Using a Claims Database.
    Kitahara K; Omura J; Wada S; Kim SW
    Pulm Ther; 2024 Mar; 10(1):21-49. PubMed ID: 37950789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of right heart catheterization in patients initiated on pulmonary arterial hypertension therapies: A population-based study.
    Duarte AG; Lin YL; Sharma G
    J Heart Lung Transplant; 2017 Feb; 36(2):220-226. PubMed ID: 27595194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary Arterial Hypertension-Specific Drug Therapy in COPD Patients with Severe Pulmonary Hypertension and Mild-to-Moderate Airflow Limitation.
    Calcaianu G; Canuet M; Schuller A; Enache I; Chaouat A; Kessler R
    Respiration; 2016; 91(1):9-17. PubMed ID: 26492415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids.
    Asche CV; Leader S; Plauschinat C; Raparla S; Yan M; Ye X; Young D
    Int J Chron Obstruct Pulmon Dis; 2012; 7():201-9. PubMed ID: 22500120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of early medication use for COPD: a population-based cohort study.
    Falk J; Dik N; Bugden S
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3101-3108. PubMed ID: 27994449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for pulmonary arterial hypertension in patients with tuberculosis-destroyed lungs and their clinical characteristics compared with patients with chronic obstructive pulmonary disease.
    Jo YS; Park JH; Lee JK; Heo EY; Chung HS; Kim DK
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2433-2443. PubMed ID: 28860738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Effectiveness of Long-Acting Beta
    Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
    Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-World Management of Patients with Pulmonary Arterial Hypertension: Insights from EXPOSURE.
    Muller A; Escribano-Subias P; Fernandes CC; Fontana M; Lange TJ; Söderberg S; Gaine S
    Adv Ther; 2024 Mar; 41(3):1103-1119. PubMed ID: 38216826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and response to pulmonary vasodilator therapies in patients with chronic obstructive pulmonary disease and pulmonary vascular phenotype.
    Steger M; Canuet M; Enache I; Goetsch T; Labani A; Meyer L; Martin G; Kessler R; Montani D; Riou M
    Respir Med; 2024; 225():107585. PubMed ID: 38479707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe pulmonary hypertension associated with COPD: hemodynamic improvement with specific therapy.
    Girard A; Jouneau S; Chabanne C; Khouatra C; Lannes M; Traclet J; Turquier S; Delaval P; Cordier JF; Cottin V
    Respiration; 2015; 90(3):220-8. PubMed ID: 26277885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of claims-based algorithms for pulmonary arterial hypertension.
    Papani R; Sharma G; Agarwal A; Callahan SJ; Chan WJ; Kuo YF; Shim YM; Mihalek AD; Duarte AG
    Pulm Circ; 2018; 8(2):2045894018759246. PubMed ID: 29480064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to Maintenance Medications among Older Adults with Chronic Obstructive Pulmonary Disease. The Role of Depression.
    Albrecht JS; Park Y; Hur P; Huang TY; Harris I; Netzer G; Lehmann SW; Langenberg P; Khokhar B; Wei YJ; Moyo P; Simoni-Wastila L
    Ann Am Thorac Soc; 2016 Sep; 13(9):1497-504. PubMed ID: 27332765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
    Wurst KE; Shukla A; Muellerova H; Davis KJ
    COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parenteral Prostanoid Use at a Tertiary Referral Center: A Retrospective Cohort Study.
    Hay BR; Pugh ME; Robbins IM; Hemnes AR
    Chest; 2016 Mar; 149(3):660-6. PubMed ID: 26378379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials in group 3 pulmonary hypertension.
    Harder EM; Waxman AB
    Curr Opin Pulm Med; 2020 Sep; 26(5):391-396. PubMed ID: 32657833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying Patients with Group 3 Pulmonary Hypertension Associated with COPD or ILD Using an Administrative Claims Database.
    Heresi GA; Dean BB; Castillo H; Lee HF; Classi P; Stafkey-Mailey D; Kantorovich A; Morland K; Sketch MR; Wu BS; King CS
    Lung; 2022 Apr; 200(2):187-203. PubMed ID: 35348836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical course of COPD patients with exercise-induced elevation of pulmonary artery pressure or less severe pulmonary hypertension presenting with respiratory symptoms and the impact of bosentan intervention-prospective, single-center, randomized, parallel-group study.
    Kashiwada T; Tanaka Y; Tanaka T; Okano T; Saito Y; Seike M; Hino M; Kimura H; Gemma A
    BMC Pulm Med; 2024 Feb; 24(1):90. PubMed ID: 38368315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension in patients with chronic obstructive pulmonary disease: advances in pathophysiology and management.
    Barberà JA; Blanco I
    Drugs; 2009 Jun; 69(9):1153-71. PubMed ID: 19537834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare resource utilization in patients with pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD): a real-world data analysis.
    Weiss T; Near AM; Zhao X; Ramey DR; Banerji T; Xie H; Nathan SD
    BMC Pulm Med; 2023 Nov; 23(1):455. PubMed ID: 37990203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.